These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31754475)
21. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway. Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition. Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737 [TBL] [Abstract][Full Text] [Related]
23. Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo. Li W; Pei S; Zhang X; Qi D; Zhang W; Dou Y; Yang R; Yao X; Zhang Z; Xie S; Fang D; Sun H Eur J Pharmacol; 2022 May; 922():174886. PubMed ID: 35292248 [TBL] [Abstract][Full Text] [Related]
24. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway. Wang G; Li L; Li Y; Zhang LH Phytomedicine; 2023 Jan; 109():154571. PubMed ID: 36610147 [TBL] [Abstract][Full Text] [Related]
25. ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9-induced deubiquitination of β-catenin to block gastric cancer metastasis. Liu J; Liu Z; Yan W; Yang H; Fang S; Deng S; Wen Y; Shen P; Li Y; Hou R; Liu X; Huang T; Li R; Zheng D; Liu Z; Fang W MedComm (2020); 2022 Dec; 3(4):e185. PubMed ID: 36448053 [TBL] [Abstract][Full Text] [Related]
26. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma. Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073 [No Abstract] [Full Text] [Related]
27. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN. Zhao M; Luo R; Liu Y; Gao L; Fu Z; Fu Q; Luo X; Chen Y; Deng X; Liang Z; Li X; Cheng C; Liu Z; Fang W Nat Commun; 2016 Apr; 7():11309. PubMed ID: 27095304 [TBL] [Abstract][Full Text] [Related]
28. NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells. Feng S; Yang G; Yang H; Liang Z; Zhang R; Fan Y; Zhang G Cell Cycle; 2017 May; 16(9):869-878. PubMed ID: 28379054 [TBL] [Abstract][Full Text] [Related]
29. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1. Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794 [TBL] [Abstract][Full Text] [Related]
30. Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in nasopharyngeal carcinoma side population cells through the miR-579-3p/SIRT1/SSRP1 axis. Ai J; Tan G; Li W; Liu H; Li T; Zhang G; Zhou Z; Gan Y Cell Biol Toxicol; 2023 Apr; 39(2):537-556. PubMed ID: 35844005 [TBL] [Abstract][Full Text] [Related]
31. TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling. Gao S; Wang S; Zhao Z; Zhang C; Liu Z; Ye P; Xu Z; Yi B; Jiao K; Naik GA; Wei S; Rais-Bahrami S; Bae S; Yang WH; Sonpavde G; Liu R; Wang L Nat Commun; 2022 May; 13(1):2792. PubMed ID: 35589707 [TBL] [Abstract][Full Text] [Related]
32. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells. Li S; Zhang X; Zhang R; Liang Z; Liao W; Du Z; Gao C; Liu F; Fan Y; Hong H Cell Cycle; 2017; 16(17):1601-1610. PubMed ID: 28749195 [TBL] [Abstract][Full Text] [Related]
33. STAT3 regulates SRGN and promotes metastasis of nasopharyngeal carcinoma through the FoxO1-miR-148a-5p-CREB1 axis. Wang YL; Ren D; Lu JL; Jiang H; Wei JZ; Lan J; Liu F; Qu SH Lab Invest; 2022 Sep; 102(9):919-934. PubMed ID: 35562411 [TBL] [Abstract][Full Text] [Related]
34. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910 [TBL] [Abstract][Full Text] [Related]
35. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma. Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269 [TBL] [Abstract][Full Text] [Related]
36. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204 [TBL] [Abstract][Full Text] [Related]
37. Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting β-catenin translocation to the nucleus through activating PI3K/Akt pathway. Zhao Q; Sun P; Qin S; Liu J Environ Toxicol; 2020 Dec; 35(12):1299-1307. PubMed ID: 32652857 [TBL] [Abstract][Full Text] [Related]
38. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis. Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592 [TBL] [Abstract][Full Text] [Related]
39. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280 [TBL] [Abstract][Full Text] [Related]
40. [High expression of MYH9 inhibits apoptosis of non-small cell lung cancer cells through activating the AKT/c-Myc pathway]. Liu F; Peng L; Xi J Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):527-536. PubMed ID: 37202187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]